IBS & irritable bowel Board decisions

The veteran's appeal is being remanded for additional development, including obtaining medical records and scheduling examinations to assess his depression, IBS, and bilateral eye disability.

The veteran's appeal is being remanded for clarification of representation, additional evidence collection, and a gynecological examination.

The Board denied the veteran's claim for an earlier effective date of June 23, 2003 for his TDIU rating based on service-connected disabilities.

The veteran's service connection claims for PTSD and IBS were denied, but his acquired psychiatric disorder was granted a higher rating of 50 percent effective June 20, 2003. His claim for hemorrhoids remains unresolved.

The Board denied service connection for the claimed conditions, including periodic accelerated heart rate, irritable bowel syndrome (IBS), numbness and swelling in the lower extremities, sleeplessness, and headaches, all of which were claimed as due to an undiagnosed illness during service.

The Board denied service connection for left ankle, left foot, and rib disorders due to a lack of competent medical evidence showing current disabilities or associations with service.

The veteran is granted a 30 percent evaluation for irritable bowel syndrome and the effective date of service connection for IBS is set at August 20, 2002.

The veteran's claims for increased evaluations and service connection have been denied. The Board found that the evidence did not meet the criteria for a higher evaluation or service connection.

The Board granted increased disability ratings of 10 percent for service-connected IBS and hemorrhoids, effective May 10, 2004.

The veteran's appeal is being remanded for a videoconference hearing at the Little Rock, Arkansas RO.

The Board has determined that the appellant's irritable bowel syndrome is attributable to service.,However, the residuals of cholecystitis, cholelithiasis, cholecystectomy (gall bladder removal), and bile duct surgery are not attributable to service or a service-connected disability.

The Board has remanded the case for additional development due to a request from the Court, including providing the veteran with notifications of VCAA provisions and scheduling him for a medical examination.

The Board has determined that new and material evidence has been submitted to reopen the claim of service connection for the cause of the veteran's death. The appellant's service-connected irritable bowel syndrome is found to have contributed to the veteran's death from metastatic colon cancer.

The Board granted a 30 percent evaluation for irritable bowel syndrome from August 11, 2000 and found that the veteran is entitled to an effective date of August 3, 1992 for service connection.

The Board has determined that service connection is not warranted for the claimed disabilities, including bilateral ankle and elbow disabilities. The veteran's complaints of pain have not been supported by clinical findings or diagnoses.

The veteran's service connection for irritable bowel syndrome was granted with a 10% initial rating, and her claim for carpal tunnel syndrome secondary to fibromyalgia was also granted. The veteran's fibromyalgia was also granted with a 10% initial rating.

The Board has determined that the veteran does not have diagnoses of certain conditions, and there is no competent medical evidence linking his military service to any current disabilities. Therefore, these claims for service connection are denied.

The veteran's service-connected disabilities do not preclude him from obtaining and retaining substantially gainful employment.

The Board has remanded the case for further development, including obtaining updated treatment records and identifying any relevant medical providers. The veteran's claim will be readjudicated to determine if a higher rating is warranted for his service-connected irritable bowel syndrome and whether new and material evidence has been received to reopen his peptic ulcer disease claim.

The Board has determined that the veteran is entitled to a 20 percent rating for fibromyalgia since April 21, 2004. The evidence shows widespread musculoskeletal pain and tender points with fatigue, sleep disturbance, stiffness, paresthesias, headache, irritable bowel symptoms, depression, anxiety, or Raynaud's-like symptoms that are nearly constant.